Table 3.
Pre- and post-treatment comparison for group 2 (LLLT)
| Pre-treatment | Post-treatment | p | |
|---|---|---|---|
| SF-Physical functioning, M±SD | 66.5±18.0 | 73.7±19.5 | 0.011a |
| SF-Role limitations due to physical health, Median (Min–Max) | 25 (0–100) | 50 (0–100) | <0.001b |
| SF-Role limitations due to emotional problems, Median (Min–Max) | 16.5 (0–100) | 33.4 (0–100) | 0.037b |
| SF-Energy/fatigue, M±SD | 44.8±21.5 | 46.4±15.5 | 0.664a |
| SF-Emotional well-being, M±SD | 56.0±18.1 | 56.3±9.9 | 0.910a |
| SF-Social functioning, Median (Min–Max) | 56.3 (25–100) | 56.3 (37.5–87.5) | 0.417b |
| SF-Pain, M±SD | 38.3±20.3 | 50.6±14.8 | 0.002a |
| SF-General health, M±SD | 49.1±14.7 | 47.5±9.0 | 0.572a |
| PRTEE, M±SD | 64.0±15.7 | 46.3±16.6 | <0.001a |
| PRTEE-Pain, M±SD | 36.6±7.2 | 27.1±8.8 | <0.001a |
| PRTEE-Functioning, M±SD | 54.7±20.1 | 38.5±17.7 | <0.001a |
| DASH, M±SD | 50.8±16.6 | 31.6±13.8 | <0.001a |
a
Paired t test;
b
Wilcoxon signed-rank test;
M: Mean; SD: Standard Deviation